A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Eli Lilly and Company
Eli Lilly and Company
Icahn School of Medicine at Mount Sinai
National Cancer Institute (NCI)
Incyclix Bio
AstraZeneca
Eli Lilly and Company
UNICANCER
Eli Lilly and Company
Ono Pharmaceutical Co. Ltd
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
OHSU Knight Cancer Institute
Eli Lilly and Company
Eli Lilly and Company